US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

208.95

-5.8500-2.72%

Post-market: 208.50-0.4500-0.22%19:56 EDT

Volume:1.42M

Turnover:298.43M

Market Cap:10.45B

PE:33.10

High:213.89

Open:213.10

Low:208.54

Close:214.80

52wk High:217.12

52wk Low:137.64

Shares:50.00M

Float Shares:50.00M

Volume Ratio:0.88

T/O Rate:2.84%

Dividend:0.41

Dividend Rate:0.20%

EPS(TTM):6.31

EPS(LYR):-1.4940

ROE:24.54%

ROA:0.10%

PB:1.28

PE(LYR):-139.86

Loading ...

Overview Company News Filings

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

Takeda receives FDA approval of NDA for Mimrylo

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Sector Update: Healthcare

MT Newswires Live

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors

Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live

Political and General News Events from August 28

PYC Therapeutics Files 2026 Corporate Governance Statement with ASX

Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push

Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares

Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV

US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment

U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens

THOMSON REUTERS

Moderna Inc. Stock Slips 4.6%, Underperforms Peers

Exchange-Traded Funds Rise as US Equities Advance After Midday

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/IBB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":208.95,"timestamp":1787947200000,"preClose":214.8,"halted":0,"volume":1420692,"hourTrading":{"tag":"盘后","latestPrice":208.5,"preClose":208.95,"latestTime":"19:56 EDT","volume":19496,"amount":4073588.5582,"timestamp":1787961384780,"change":-0.45,"changeRate":-0.002154,"amplitude":0.002154},"delay":0,"changeRate":-0.027234636871508483,"floatShares":50000000,"shares":50000000,"eps":6.311863,"marketStatus":"Market Closed","change":-5.85,"latestTime":"08-28 16:00:00 EDT","open":213.095,"high":213.89,"low":208.54,"amount":298428416.27508,"amplitude":0.024907,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":214.8,"sharesOutstanding":49450000,"nav":208.979543,"aum":10469875104.3,"dividendRate":0.001957,"bidAskSpread":0.000356,"preHourTrading":{"tag":"盘前","latestPrice":213.5,"preClose":214.8,"latestTime":"09:16 EDT","volume":1784,"amount":383702.29183999996,"timestamp":1787923011851,"change":-1.3,"changeRate":-0.006052,"amplitude":0.015829},"postHourTrading":{"tag":"盘后","latestPrice":208.5,"preClose":208.95,"latestTime":"19:56 EDT","volume":19496,"amount":4073588.5582,"timestamp":1787961384780,"change":-0.45,"changeRate":-0.002154,"amplitude":0.002154},"volumeRatio":0.8819865165205065,"impliedVol":0.2419,"impliedVolPercentile":0.6454},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50000000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":0.8819865165205065,"shares":50000000,"dividePrice":0.4089,"high":213.89,"amplitude":0.024907,"preClose":214.8,"low":208.54,"week52Low":137.635,"pbRate":"1.28","psRate":"251.36","week52High":217.12,"institutionHeld":0,"latestPrice":208.95,"eps":6.311863,"divideRate":0.001957,"volume":1420692,"delay":0,"ttmEps":6.311863,"open":213.095,"prevYearClose":168.77,"prevWeekClose":213.56,"prevMonthClose":186.41,"prevQuarterClose":190.19,"fiveDayClose":213.56,"twentyDayClose":186.41,"sixtyDayClose":167.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663043488","title":"Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2663043488","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663043488?lang=en_us&edition=fundamental","pubTime":"2026-08-30 07:30","pubTimestamp":1788046226,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong gains over the past few years, yet current valuation checks still suggest the shares screen as inexpensive on several metrics. The question for investors is how that strong track record and the latest product approvals align with a profile that continues to lean cheap.\n\nOver 5 years the stock has returned about 143%, which puts recent moves in the context of a long, powerful run that investors now need to judge against today’s pricing.\nThe...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-stays-cheap-after-a-143-five-year-run","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4550","LU1066053197.SGD","IE00B3T34201.USD","LU1934455863.HKD","BIB","LU0234570918.USD","LU2112291526.USD","TMED","BK4578","LU0114720955.EUR","BK4585","LU0882574055.USD","LU0289739699.SGD","LU1571399168.USD","BK4588","GILD","BK4583","LU0122379950.USD","LU1023059063.AUD","LU2089984988.USD","LU1934455194.USD","LU2468319806.SGD","SG9999015945.SGD","BK4139","IBBQ","SG9999015978.USD","LU0965509010.AUD","BMED","IBB","LU0965508806.USD","BK4532","IE00BZ1G4Q59.USD","TBXU","IE00B19Z3B42.SGD","LU2324357040.USD","LU0109394709.USD","LU1061106388.HKD","LU0058720904.USD","BK4566","BBH","LU1934455277.USD","MEDI","LU1839511570.USD","BK4568","LU0823416689.USD","LU1430594728.SGD","LU1066051498.USD","IE00BKVL7J92.USD","LU0965509283.SGD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663019703","title":"Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO","url":"https://stock-news.laohu8.com/highlight/detail?id=2663019703","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663019703?lang=en_us&edition=fundamental","pubTime":"2026-08-29 08:52","pubTimestamp":1787964735,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co ( ($JP:4502) ) just unveiled an announcement. Takeda has secured U.S. FDA approval for MIMRYLO (rusfertide), a first-in-cl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-wins-fda-nod-for-first-in-class-polycythemia-vera-therapy-mimrylo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PINK","BK4585","MEDI","MRNY","MRNX","NVIB","IDNA","BBP","PSCH","LFSC","TBXU","XLVX","BMED","RSPH","GNMX","TECB","IEIH","SYNB","GDOC","IBB","IYH","FRTY","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016033","title":"Takeda receives FDA approval of NDA for Mimrylo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016033","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663016033?lang=en_us&edition=fundamental","pubTime":"2026-08-29 07:00","pubTimestamp":1787958013,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced U.S. FDA approval of the New Drug Application for Mimrylo for the treatment of erythrocytosis in adults with polycythemia ve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-receives-fda-approval-of-nda-for-mimrylo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TBXU","GDOC","LABU","SYNB","IEIH","LFSC","MEDI","PSCH","BK4007","BK4585","PINK","IBB","TAK","GNMX","BK4588","TECB","NVIB","FRTY","MRNX","IYH","BMED","MRNY","IDNA","XLVX","RSPH","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015099","title":"Crinetics Shareholders Approve Vertex Acquisition at Special Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015099","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015099?lang=en_us&edition=fundamental","pubTime":"2026-08-29 05:33","pubTimestamp":1787952818,"startTime":"0","endTime":"0","summary":"Crinetics Pharmaceuticals ( ($CRNX) ) has provided an update. On August 28, 2026, Crinetics Pharmaceuticals shareholders held a special meeting at ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-shareholders-approve-vertex-acquisition-at-special-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234570918.USD","BK4585","LU1778281490.HKD","LU2468319806.SGD","BK4532","LU0079474960.USD","GNMX","TBXU","LU0823416689.USD","LU0061475181.USD","LU2324357040.USD","LU1815336091.USD","LU2417539215.USD","LU0757428866.USD","IE00B894F039.SGD","IE00B19Z3581.USD","BIB","BK4023","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE00BZ9MQY76.HKD","LU1430594728.SGD","LU0432979614.USD","BBH","LU0256863811.USD","PBE","LU2362540622.SGD","LU1093756168.USD","BK4567","IBBQ","LU1069344957.HKD","IE0009355771.USD","LU2462157665.USD","BK4533","BK4588","IE00B19Z3B42.SGD","LU1674673691.USD","IE00B19Z9P08.USD","LU0289739699.SGD","LU0566484027.USD","LU1674673428.USD","SG9999001176.SGD","VERX","VRTX","LU2236285917.USD","IBB","IDNA","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663701587","title":"Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663701587","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663701587?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:35","pubTimestamp":1787949300,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 2.14% to $145.68 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.Gilead Sciences Inc. closed 7.38% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and Abbott Laboratories  rose 0.79% to $112.47.Trading volume  remained 3.2 million below its 50-day average volume of 7.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455194.USD","BK4588","BK4550","IE00BZ1G4Q59.USD","LU0114720955.EUR","SG9999015986.USD","TBXU","BBH","LU2324357040.USD","BMED","BK4568","LU0823416689.USD","LU1023059063.AUD","LU1037948541.HKD","IBB","LU1674673691.USD","IE00B3T34201.USD","LU1066051498.USD","LU1057294990.SGD","SG9999015952.SGD","LU2468319806.SGD","GILD","LU0882574055.USD","LU0058720904.USD","TMED","IBBQ","LU0889565916.HKD","SG9999015978.USD","IE0002270589.USD","LU0965508806.USD","MEDI","LU1430594728.SGD","LU1674673428.USD","LU0234570918.USD","LU0861579265.USD","LU0289739699.SGD","BK4566","LU0965509283.SGD","LU1571399168.USD","IE00B7SZLL34.SGD","LU0965509101.SGD","LU1778281490.HKD","LU1934455863.HKD","LU1066053197.SGD","SG9999015945.SGD","IE00BSNM7G36.USD","LU1839511570.USD","BK4139","BK4583","LU2087621335.USD","LU0122379950.USD","LU1934455277.USD","LU1037948897.HKD","IE00B19Z3581.USD","LU0965509010.AUD","LU2089984988.USD","IE00BKVL7J92.USD","LU2112291526.USD","BK4578","LU1585245621.USD","LU2357627491.SGD","LU0109394709.USD","LU0859254822.USD","IE00B19Z3B42.SGD","BIB","LU0320765992.SGD","LU1061106388.HKD","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663015807","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663015807","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663015807?lang=en_us&edition=fundamental","pubTime":"2026-08-29 04:34","pubTimestamp":1787949240,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  slipped 1.05% to $432.42 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.25% to 7,711.76 and Dow Jones Industrial Average  falling 0.02% to 53,559.99.This was the stock's fourth consecutive day of losses.Amgen Inc. closed 3.27% below its 52-week high of $447.03, which the company reached on August 25th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.85% to $268.04, Pfizer Inc.  fell 0.21% to $27.96, and AbbVie Inc.  fell 1.03% to $255.48.Trading volume  remained 889,592 below its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IBB","LU1057294990.SGD","LU2242646821.SGD","TBXU","LU1571399168.USD","BK4534","SG9999001440.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU0889565916.HKD","IE0002141913.USD","LU2242652126.USD","BK4599","BIB","LU0868494617.USD","IE00B4R5TH58.HKD","IE0009355771.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","BBH","BK4566","BK4581","AMGN","LU1983299246.USD","PJP","PBE","BK4585","LU2112291526.USD","LU0058720904.USD","IBBQ","BK4533","LU1061106388.HKD","BK4139","LU1023059063.AUD","04332","BK4588","LU0109394709.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013365","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013365","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013365?lang=en_us&edition=fundamental","pubTime":"2026-08-29 03:33","pubTimestamp":1787945609,"startTime":"0","endTime":"0","summary":"Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each shedding 0.4%.The iShares Biotechnology ETF  dropped 2.7%.In corporate news, 10x Genomics  said a Delaware federal jury awarded the company more than $4.8 million after finding that three patents held through its Scale Biosciences unit were infringed by Parse Biosciences, a subsidiary of Qiagen . 10x Genomics shares were down 5.2%, and Qiagen was shedding 1.3%.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0128526141.USD","BK4548","TXG","LU2125909247.SGD","BK4581","IBB","BK4585","LU1861559042.SGD","BK4588","ARKG","LU0963586101.USD","LU1923622614.USD","LU0029874061.USD","LU2433249047.HKD","XBI","QGEN","FMED","LU1861558580.USD","LABU","BK4137","HCSG","BK4121","XLV","LU2125909593.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663018885","title":"Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo","url":"https://stock-news.laohu8.com/highlight/detail?id=2663018885","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663018885?lang=en_us&edition=fundamental","pubTime":"2026-08-29 01:20","pubTimestamp":1787937637,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock was down roughly 2% on Friday alongside an FDA update concerning HIV drug Bixlenvo.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/gilead-sciences-stock-gild-slips-2-despite-fda-approval-of-bixlenvo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIB","LU0320765992.SGD","LU0114720955.EUR","TBXU","LU1057294990.SGD","IE00B19Z3581.USD","IBB","SG9999015986.USD","SG9999015945.SGD","LU2112291526.USD","BK4566","BK4532","LU1037948541.HKD","LU0109394709.USD","LU1934455194.USD","LU1934455863.HKD","LU1066051498.USD","IE00B3T34201.USD","IE00BKVL7J92.USD","GILD","LU0122379950.USD","LU1674673691.USD","LU2357627491.SGD","LU0965509010.AUD","BK4585","IBBQ","BK4588","SG9999015978.USD","LU1585245621.USD","BK4578","BMED","BBH","LU0823416689.USD","LU0889565916.HKD","MEDI","LU1778281490.HKD","IE0002270589.USD","LU0882574055.USD","LU1037948897.HKD","LU1066053197.SGD","LU1571399168.USD","LU1934455277.USD","TMED","LU0965509101.SGD","BK4139","LABU","IE00B19Z3B42.SGD","LU0859254822.USD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663097210","title":"Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663097210","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663097210?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934634,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. Vertex’s new Phase 1 study, officially titled “A Phase 1, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-tests-vx-407s-impact-on-birth-control-what-it-means-for-vrtx-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362541273.HKD","LU0889565916.HKD","IDNA","IBB","LU1430594728.SGD","LU0566484027.USD","GNMX","VRTX","BK4588","LU0320765992.SGD","SG9999013999.USD","VERX","LU2362541513.USD","BK4139","SGXZ57979304.SGD","PBE","IE00B2B36J28.USD","IE00B19Z9Z06.USD","LU1585245621.USD","BK4211","LU0058720904.USD","LU0417517546.SGD","IE00BZ9MQY76.HKD","LU2324357040.USD","SG9999001176.SGD","IBBQ","IE00B19Z3581.USD","BK4532","BK4585","IE0009355771.USD","LU2362540622.SGD","LU2417539215.USD","TBXU","IE00B894F039.SGD","IE00BJT1NW94.SGD","ISBC","BK4567","IE0002270589.USD","LU2237438978.USD","SG9999001176.USD","LU0823416689.USD","LU1093756325.SGD","BK4023","BBH","BIB","LU1674673428.USD","LU2468319806.SGD","LU2089984988.USD","LU1815336091.USD","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663225097","title":"Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2663225097","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663225097?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934627,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s latest psoriasis study update spotlights apremilast (AMG 407) for ki...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-wrap-up-what-apremilast-safety-data-means-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-pediatric-psoriasis-study-wrap-up-what-apremilast-safety-data-means-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","LU0058720904.USD","LU2089984988.USD","LU2242646821.SGD","PJP","BK4533","IE00B2B36J28.USD","LU2112291526.USD","BK4585","IE00BFTCPJ56.SGD","PBE","LU0122379950.USD","LU1023059063.AUD","LU0109394709.USD","ISBC","BBH","BK4599","LU0868494617.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU2242652126.USD","IE0009355771.USD","AMGN","LU0320765992.SGD","BIB","IE00B4R5TH58.HKD","SG9999001440.SGD","LU2468319806.SGD","BK4588","LU0889565916.HKD","BK4211","BK4139","IBB","LU1057294990.SGD","LU1571399168.USD","LU1061106388.HKD","IBBQ","IE00BJT1NW94.SGD","BK4581","LU0289739699.SGD","LU1983299246.USD","BK4566","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662966095","title":"Sector Update: Health Care Stocks Mixed Pre-Bell Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2662966095","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662966095?lang=en_us&edition=fundamental","pubTime":"2026-08-28 21:17","pubTimestamp":1787923054,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed premarket Friday, with the State Street Health Care Select Sector SPDR ETF  gaining by 0.1% and the iShares Biotechnology ETF  down 0.6%.Cytokinetics  shares were down 4%, extending the 1.6% loss in the previous session. The company said Friday that its phase 3 clinical trial of aficamten in symptomatic non-obstructive hypertrophic cardiomyopathy met both primary endpoints.Hutchmed's  stock was up 1% after the company said a new drug application for fanregratinib to treat liver cancer has been granted conditional approval by China's National Medical Products Administration.Eli Lilly  stock was up 0.5% after the company said the US Food and Drug Administration approved Mounjaro to lower the risk of major adverse cardiovascular events in adults with type 2 diabetes who are at high risk for those events.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CYTK","LU0096364046.USD","LU1983299246.USD","LLYZ","SG9999018857.SGD","IE00B1XK9C88.USD","LU0432979614.USD","LU1804176565.USD","OZEM","LU0079474960.USD","BK4505","LU0097036916.USD","IE00BJJMRX11.SGD","LU0708995401.HKD","LU2168564495.EUR","SG9999015945.SGD","XLV","HCM","LU2552382132.HKD","IE00BJLML261.HKD","00013","LU0354030438.USD","LABU","LU0889565916.HKD","LU2471134952.CNY","LU2471134879.HKD","LU0158827781.USD","LU1917777945.USD","LU2168564149.EUR","CURE","LU0964807845.USD","LU0787776722.HKD","LU2111349929.HKD","LU2471134523.USD","THNR","JDOC","IE00BK4W5L77.USD","LU1069344957.HKD","IXJ","LU0640476718.USD","MEDX","LLYX","LU0289739699.SGD","LU0122379950.USD","HRTS","LU0114720955.EUR","LU0316494557.USD","LU2265009873.SGD","IE00BFSS8Q28.SGD","LU2552382215.SGD","LU2237443549.SGD","LLII","BK4581","LU2357305700.SGD","BK4599","IE00B2B36J28.USD","LU1720051108.HKD","LU2089284900.SGD","LU0820561818.USD","LU2491050071.SGD","FTXH","LU2756315318.SGD","IE00B1BXHZ80.USD","CANC","LU1551013425.SGD","LU0345770308.USD","RXL","SG9999015978.USD","LU0266013472.USD","LU0109394709.USD","LU0094547139.USD","LU0106261372.USD","LU2106854487.HKD","SG9999014906.USD","LU1280957306.USD","IYH","ILDR","LU2168564065.EUR","LU0823434740.USD","IE00B7KXQ091.USD","LU2491049909.HKD","LU2461242641.AUD","IE00BJJMRZ35.SGD","LU0320765059.SGD","LU1023059063.AUD","LU2237443895.HKD","MHIP","LLY","LU0466842654.USD","LU0943347566.SGD","LU2108987350.USD","SG9999001176.USD","LU1127390331.HKD","IE0004445015.USD","BK4585","IE0002141913.USD","IE00BFSS7M15.SGD","IE00BJT1NW94.SGD","LU0225283273.USD","LU0471298777.SGD","LU2271345857.HKD","LU2462591350.SGD","LU2471134796.USD","PPH","LU2023250330.USD","LU1548497426.USD","LU2028103732.USD","LU0471298694.HKD","LU2213496289.HKD","LU2468319806.SGD","LU2087625088.SGD","BK4533","TRUH","LU1989771016.USD","LU2089283258.USD","LU1712237335.SGD","LU1623119135.USD","LU2491050154.USD","BK4534","LU2063271972.USD","LU0456855351.SGD","IE0004445239.USD","XBI","LU1868836757.USD","IE00BK4W5M84.HKD","IE00BN29S564.USD","LU2746668974.SGD","LU0353189680.USD","SG9999015952.SGD","LU2023251221.USD","LU1974910355.USD","LU2756315664.SGD","MEDI","IBB","SG9999013999.USD","LU0786609619.USD","LU2361044949.HKD","SG9999014898.SGD","FHLC","LU0238689110.USD","BK4007","LU0256863902.USD","LU0820562030.AUD","LU1868837136.USD","GB00BDT5M118.USD","LU0345770993.USD","LU1988902786.USD","LU2168564222.USD","LU0820561909.HKD","LU1814569148.SGD","LU1057294990.SGD","LU1979441026.SGD","LU1366192091.USD","LU0882574055.USD","LU0210536198.USD","IHE","LU1035775433.USD","LU2237443622.USD","LU0203201768.USD","LU0354030511.USD","SGXZ31699556.SGD","BK4531","LU1868837300.USD","LU2112291526.USD","SG9999018865.SGD","BK4588","LU2602419157.SGD","LU1093756325.SGD","LU2456880835.USD","LU2360106947.USD","AGNG","SG9999001176.SGD","LU0672654240.SGD","LU1267930730.SGD","LU1629891620.HKD","SGXZ51526630.SGD","LU2462157665.USD","LU2750360997.AUD","SGXZ99366536.SGD","LU2089984988.USD","ELIS","LU0882574139.USD","LU1868836914.USD","LU2750360641.GBP","LU2552382058.USD","LU0320765992.SGD","IE00BJJMRY28.SGD","LU2264538146.SGD","IE0009355771.USD","SG9999014880.SGD","IE00BKPKM429.USD","LU0689472784.USD","GDOC","LU1720051017.SGD","SG9999015986.USD","LU0133085943.USD","SGXZ81514606.USD","IE00BKDWB100.SGD","LU2896262040.SGD","LU0353189763.USD","WDNA","BK4139","LU1551013342.USD","LU2237443382.USD","LU1323610961.USD","LU2361045086.USD","LU0058720904.USD","LU0823416689.USD","SGXZ57979304.SGD","IE00BWXC8680.SGD","BK4516","LU0061475181.USD","IE00BFTCPJ56.SGD","LU0203202063.USD","LU2324357040.USD","IE00B4R5TH58.HKD","LU1093756168.USD","LU1145028129.USD","LU1291159041.SGD","LU0109391861.USD","LU1691799644.USD","LU0385154629.USD","LU2023250504.SGD","LU0234572021.USD","LU2168563687.JPY","LU2211815571.USD","TMED","SG9999017495.SGD","LU2237443465.HKD","LU0323591593.USD","LU1232071149.USD","ELIL","LU0158827948.USD","LU1061106388.HKD","IE0005OL40V9.USD","LU2236285917.USD","LU2361044865.SGD","IE0001KFT4U8.USD","LU1064131342.USD","LU0683600562.USD","PJP","IE00B775H168.HKD","IE00B4JS1V06.HKD","LU1868836591.USD","LU2237438978.USD","LU0823434583.USD","LU2237443978.SGD","SG9999014914.USD","LU2417539215.USD","LU0006306889.USD","LU0256863811.USD","LU0198837287.USD","LU0174119429.USD","LU2746668461.USD","LU0417517546.SGD","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662098405","title":"Political and General News Events from August 28","url":"https://stock-news.laohu8.com/highlight/detail?id=2662098405","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662098405?lang=en_us&edition=fundamental","pubTime":"2026-08-28 20:30","pubTimestamp":1787920229,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 28Aug 28 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL4N44P0YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","TBXU","IBBQ","LU0058720904.USD","PJP","IE00BFTCPJ56.SGD","BK4566","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0889565916.HKD","LU1057294990.SGD","LU2112291526.USD","LU2242652126.USD","LU0289739699.SGD","LU2242646821.SGD","IE0002141913.USD","PBE","BK4581","IE00B4R5TH58.HKD","LU1061106388.HKD","SG9999001440.SGD","BBH","IBB","LU0109394709.USD","BK4585","IE00B2B36J28.USD","LU0320765992.SGD","BK4139","BIB","LU2089984988.USD","LU0868494617.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4599","LU1571399168.USD","LU1983299246.USD","BK4533","LU2468319806.SGD","AMGN","BK4588","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662065799","title":"PYC Therapeutics Files 2026 Corporate Governance Statement with ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2662065799","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662065799?lang=en_us&edition=fundamental","pubTime":"2026-08-28 17:28","pubTimestamp":1787909297,"startTime":"0","endTime":"0","summary":"PYC Therapeutics Limited ( ($AU:PYC) ) just unveiled an update. PYC Therapeutics Limited is an Australia-listed biotechnology company that disclose...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-files-2026-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pyc-therapeutics-files-2026-corporate-governance-statement-with-asx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","AGNG","BK4585","FHLC","BK4007","RSPH","BK4588","XT","LENZ","IBB","BBP","SYNB","IEIH","BK4139","LNGR","JDOC","DARP","FWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662762030","title":"Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2662762030","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662762030?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:17","pubTimestamp":1787883449,"startTime":"0","endTime":"0","summary":"Gilead breaks ground on Foster City biologics facility in $32 billion US investment pushGilead broke ground on its Chess biologics facility at its Foster City, California headquarters as part of a pla","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL98vB5b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BMED","BK4578","LU0965509101.SGD","TBXU","LU1037948541.HKD","BBH","LU0109394709.USD","LU0889565916.HKD","SG9999015952.SGD","LU1061106388.HKD","LU0859254822.USD","BK4568","LU1066053197.SGD","LU1037948897.HKD","IBB","IE00BKVL7J92.USD","LU1430594728.SGD","IE00BSNM7G36.USD","IBBQ","BIB","BK4583","BK4588","IE0002270589.USD","LU0320765992.SGD","LU2087621335.USD","TMED","LU1934455194.USD","LU2357627491.SGD","LU0965509283.SGD","LU2468319806.SGD","LU0234570918.USD","LU0823416689.USD","LU0289739699.SGD","MEDI","LU1934455863.HKD","IE00B7SZLL34.SGD","LU1674673691.USD","LU0965509010.AUD","LU1674673428.USD","LU0058720904.USD","GILD","LU2112291526.USD","LU0861579265.USD","LU0965508806.USD","LU1057294990.SGD","IE00B19Z3581.USD","LU1066051498.USD","LU1571399168.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662394370","title":"Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662394370","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662394370?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:45","pubTimestamp":1787870729,"startTime":"0","endTime":"0","summary":"Gilead Sciences director Anthony Welters disposes of USD 2.64 million in common sharesGilead director Anthony Welters exercised stock options for 18,000 shares on Aug. 26, 2026 at prices of USD 60.67 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL29Bbzm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BIB","LU1839511570.USD","LU1571399168.USD","BK4585","BK4139","LU0965509101.SGD","LU1585245621.USD","BBH","MEDI","LU1934455863.HKD","LU0058720904.USD","BK4583","GILD","IE00B3T34201.USD","LU0861579265.USD","IE00B19Z3581.USD","LU1066051498.USD","LU0965509010.AUD","BK4588","LU0320765992.SGD","IE00BSNM7G36.USD","LU1037948897.HKD","LU0122379950.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU2112291526.USD","LU0823416689.USD","BK4532","TMED","IE0002270589.USD","LU1430594728.SGD","LU0889565916.HKD","LU2087621335.USD","TBXU","LU2324357040.USD","LU0289739699.SGD","IE00B7SZLL34.SGD","LU0109394709.USD","LU1057294990.SGD","IBB","IBBQ","LU1674673428.USD","LU0965508806.USD","BK4578","SG9999015986.USD","BK4566","LU0859254822.USD","BMED","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036059","title":"Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036059","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036059?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:55","pubTimestamp":1787867719,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences announced that the FDA approved Bixlenvo – bictegravir 75 mg/lenacapavir 50 mg -, the smallest once-daily single tablet regi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU2324357040.USD","LU1934455194.USD","LU1023059063.AUD","LU0122379950.USD","IBB","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU1066053197.SGD","LU1674673428.USD","LU1934455863.HKD","LU1571399168.USD","LU0234570918.USD","BIB","SG9999015945.SGD","BMED","LU1037948897.HKD","TMED","LU1839511570.USD","IBBQ","BBH","SG9999015986.USD","LU1585245621.USD","TBXU","BK4583","BK4139","BK4585","BK4566","BK4568","LU0889565916.HKD","LU0965509101.SGD","LU1061106388.HKD","LU1057294990.SGD","LU2087621335.USD","LU0859254822.USD","LU0823416689.USD","BK4588","LU0965509283.SGD","GILD","BK4532","LU2357627491.SGD","LU0058720904.USD","LU1066051498.USD","IE00B19Z3581.USD","LU0861579265.USD","MEDI","IE00B19Z3B42.SGD","LU1674673691.USD","SG9999015952.SGD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036301","title":"US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036301","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036301?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:50","pubTimestamp":1787867441,"startTime":"0","endTime":"0","summary":"US FDA approves Gilead's once-daily combination pill for HIV treatmentAug 27 -The U.S. Food and Drug Administration has approved Gilead Sciences'GILD.Oonce daily oral combination pill for treatment of adults whose HIV has already been reduced to very low levels, the company said on Thursday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4N44O24M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0965509010.AUD","BK4139","LU1585245621.USD","LU0122379950.USD","LU1061106388.HKD","LU1934455863.HKD","LU0114720955.EUR","LU1934455277.USD","IBB","IE00B19Z3B42.SGD","LU1066051498.USD","SG9999015945.SGD","LU2357627491.SGD","LU0889565916.HKD","BK4578","IE00B3T34201.USD","LU1674673428.USD","BK4583","IE00B7SZLL34.SGD","LU0965509101.SGD","LU0861579265.USD","IE0002270589.USD","LU2324357040.USD","TMED","GILD","LU0882574055.USD","BMED","LU0234570918.USD","LU0289739699.SGD","LU0320765992.SGD","LU1037948541.HKD","LU1037948897.HKD","LU2468319806.SGD","LU1778281490.HKD","IE00B19Z3581.USD","LU1057294990.SGD","BK4585","IBBQ","BBH","LU1839511570.USD","SG9999015952.SGD","LU0965508806.USD","TBXU","MEDI","BIB","LU1023059063.AUD","BK4566","IE00BZ1G4Q59.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036807","title":"U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036807","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036807?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:47","pubTimestamp":1787867220,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUA7M9KZ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","LU0289739699.SGD","LU1057294990.SGD","IBB","LU1839511570.USD","BK4583","TBXU","LU1571399168.USD","LU1934455194.USD","LU1430594728.SGD","TMED","BMED","LU0320765992.SGD","LU0889565916.HKD","SG9999015978.USD","LU0965509010.AUD","BIB","LU1066051498.USD","LU2089984988.USD","LU0882574055.USD","BK4532","LU1934455863.HKD","LU1934455277.USD","LU0861579265.USD","IE00B19Z3B42.SGD","BBH","BK4566","LU0234570918.USD","BK4585","LU2112291526.USD","LU1061106388.HKD","IBBQ","BK4568","MEDI","LU2087621335.USD","LU1037948897.HKD","IE00BKVL7J92.USD","LU0965509283.SGD","IE00B7SZLL34.SGD","BK4588","BK4550","LU0823416689.USD","GILD","LU1066053197.SGD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU0109394709.USD","BK4578","LU1778281490.HKD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662033626","title":"Moderna Inc. Stock Slips 4.6%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033626","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662033626?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:34","pubTimestamp":1787862840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. slid 4.6% to $142.77 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.6% to 26,541.35 and the Dow Jones Industrial Average rising 0.2% to 53,569.44.This was the stock's second consecutive day of losses.Moderna Inc. closed 19.2% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.6% to $265.77, Pfizer Inc. fell 1.0% to $28.02, and Gilead Sciences Inc. rose 0.52% to $148.86.Trading volume totaled 24.9 million, compared to the 50-day average of 16.4 million.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU0965508806.USD","LU2468319806.SGD","LU0320765992.SGD","LU0114720955.EUR","TBXU","MRNA","IE00B19Z3581.USD","GNOM","IBB","SG9999015986.USD","SG9999015945.SGD","MRNY","LU1674673428.USD","LU1037948541.HKD","LU1934455194.USD","LU1061106388.HKD","LGHT","BK4534","IE00BKVL7J92.USD","BK4568","GILD","LU2357627491.SGD","BK4583","IDNA","LU0058720904.USD","IBBQ","LU2324357040.USD","LU0965509283.SGD","BK4588","BK4551","WDNA","BK4533","BBH","BMED","LU0889565916.HKD","MEDI","MRNX","LU0861579265.USD","LU1066053197.SGD","LU1571399168.USD","LU1934455277.USD","SG9999015952.SGD","TMED","BK4139","LU1674673691.USD","LU0109394709.USD","LU0965509010.AUD","IE00B7SZLL34.SGD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662828380","title":"Exchange-Traded Funds Rise as US Equities Advance After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2662828380","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662828380?lang=en_us&edition=fundamental","pubTime":"2026-08-28 01:09","pubTimestamp":1787850562,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV were higher. Actively traded Invesco QQQ Trust (QQQ) added 1.2%.US equity indexes rose after Nvidia's (NVDA) strong fiscal Q2 resu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":[".DJI","SPYM","IYE","IYJ","XLF","RTH.AU","SPHD","STT","SLV","STCE",".SPX","FDN","IBB","ETH","XLV","IYW","EETH","GLD","VHT.AU","XLY","IYH","IYK","QQQ","USO","VIS","BTF","SQQQ","RSPU","XLI","BETE","BITO",".IXIC","ARTY","IGM","RTH","XSD","FAS","UNG","XRT","SOXX","SPDN","FAZ","BETH","XLE","VDC","XLP","XLK","ARKY","NVDA","VHT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}